Daniel Kim
Associate Professor UC San Diego & NIH
Dr. Daniel Kim is an Assistant Professor at the University of California Santa Cruz, an Associate Member of the Stanford Canary Center, and a Research Scholar of the American Cancer Society. He is also Co-Chair of the National Institutes of Health (NIH) Liquid Biopsy Scientific Interest Group and Co-Chair of the International Society for Extracellular Vesicles (ISEV) RNA Task Force. His laboratory develops RNA liquid biopsy technology for precision oncology and cancer early detection. His research has been featured in Newsweek, Scientific American, and by the Director of the National Institutes of Health and has been recognized by awards from the Damon Runyon Cancer Research Foundation and the National Academy of Sciences.
Seminars
- Discovering novel cell-free RNA biomarkers through longread nanopore sequencing and machine learning to expand opportunities for early cancer and precancer detection
- Revealing dynamic tumor and host biology beyond genomic alterations to inform patient stratification, therapeutic response monitoring, and oncology drug development
- Integrating cell-free RNA with ctDNA, AI, and multimodal clinical data to advance next-generation liquid biopsy platforms for precision oncology
